Cholesteatoma triggering squamous cell carcinoma: case report and literature review of a rare tumor

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 30, Issue 4, 2009, Pages 256-260

  Rothschild, Sacha ^a,b   Ciernik, I Frank ^a,c   Hartmann, Matthias ^a   Schuknecht, Bernhard ^d   Lütolf, Urs M ^a   Huber, Alexander M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^d MRI Medical Radiological Institute Zurich   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANAMNESIS; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CASE REPORT; CHOLESTEATOMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MASTOIDECTOMY; OTORRHEA; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TYMPANOPLASTY;

AGED; CARCINOMA, SQUAMOUS CELL; CHOLESTEATOMA; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; EAR DISEASES; FATAL OUTCOME; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; SKULL NEOPLASMS; TEMPORAL BONE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TYMPANOPLASTY;

EID: 67649212969     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2008.06.011     Document Type: Review

References (39)

1. Kemppainen H.O., Puhakka H.J., Laippala P.J., et al. Epidemiology and aetiology of middle ear cholesteatoma. Acta Otolaryngol 119 (1999) 568-572
2. Takahashi K., Yamamoto Y., Sato K., et al. Middle ear carcinoma originating from a primary acquired cholesteatoma: a case report. Otol Neurotol 26 (2005) 105-108
3. Westerman S.T., Sylvia L.C., and Tepper E. Carcinoma arising out of a primary acquired cholesteatoma. J Med Soc N J 78 (1981) 600-602
4. Arriaga M., Curtin H., Takahashi H., et al. Staging proposal for external auditory meatus carcinoma based on preoperative clinical examination and computed tomography findings. Ann Otol Rhinol Laryngol 99 9 Pt 1 (1990) 714-721
5. National Cancer Institute. National Cancer Institute common toxicity criteria, version 3.0 (2003), National Cancer Institute, Bethesda (Mass)
6. Nyrop M., and Grontved A. Cancer of the external auditory canal. Arch Otolaryngol Head Neck Surg 128 (2002) 834-837
7. Prasad S., and Janecka I.P. Efficacy of surgical treatments for squamous cell carcinoma of the temporal bone: a literature review. Otolaryngol Head Neck Surg 110 (1994) 270-280
8. Takano A., Takasaki K., Kumagami H., et al. A case of bilateral middle-ear squamous cell carcinoma. J Laryngol Otol 115 (2001) 815-818
9. Murray E.C., and Wiltshire C.R. Synchronous bilateral middle ear carcinoma. Clin Oncol (R Coll Radiol) 6 (1994) 57
10. Suzuki K., Takahashi M., Ito Y., et al. Bilateral middle ear squamous cell carcinoma and clinical review of an additional 5 cases of middle ear carcinomas. Auris Nasus Larynx 26 (1999) 33-38
11. Gillespie M.B., Francis H.W., Chee N., et al. Squamous cell carcinoma of the temporal bone: a radiographic-pathologic correlation. Arch Otolaryngol Head Neck Surg 127 (2001) 803-807
12. Pfreundner L., Schwager K., Willner J., et al. Carcinoma of the external auditory canal and middle ear. Int J Radiat Oncol Biol Phys 44 (1999) 777-788
13. Hahn S.S., Kim J.A., Goodchild N., et al. Carcinoma of the middle ear and external auditory canal. Int J Radiat Oncol Biol Phys 9 (1983) 1003-1007
14. Lewis J.S. Surgical management of tumors of the middle ear and mastoid. J Laryngol Otol 97 (1983) 299-311
15. Moffat D.A., Wagstaff S.A., and Hardy D.G. The outcome of radical surgery and postoperative radiotherapy for squamous carcinoma of the temporal bone. Laryngoscope 115 (2005) 341-347
16. Dingwell R.T., Leslie K.E., Sabour P., et al. Influence of the genotype of Staphylococcus aureus, determined by pulsed-field gel electrophoresis, on dry-period elimination of subclinical mastitis in Canadian dairy herds. Can J Vet Res 70 (2006) 115-120
17. Golding-Wood D.G., Quiney R.E., and Cheesman A.D. Carcinoma of the ear: retrospective analysis of 61 patients. J Laryngol Otol 103 (1989) 653-656
18. Birzgalis A.R., Keith A.O., and Farrington W.T. Radiotherapy in the treatment of middle ear and mastoid carcinoma. Clin Otolaryngol Allied Sci 17 (1992) 113-116
19. Lewis J.S. Squamous carcinoma of the ear. Arch Otolaryngol 97 (1973) 41-42
20. Morton R.P., Stell P.M., and Derrick P.P. Epidemiology of cancer of the middle ear cleft. Cancer 53 (1984) 1612-1617
21. Moffat D.A., and Wagstaff S.A. Squamous cell carcinoma of the temporal bone. Curr Opin Otolaryngol Head Neck Surg 11 (2003) 107-111
22. Michaels L., and Wells M. Squamous cell carcinoma of the middle ear. Clin Otolaryngol Allied Sci 5 (1980) 235-248
23. Kuijpers W., Vennix P.P., Peters T.A., Ramaekers F.C., et al. Acta Otolaryngol 116 (1996) 293-298
24. Bergmann K., Hoppe F., He Y., et al. Human-papillomavirus DNA in cholesteatomas. Int J Cancer 59 (1994) 463-466
25. Walboomers J.M., Jacobs M.V., Manos M.M., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
26. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2 (2002) 342-350
27. Munoz N., Bosch F.X., de Sanjose S., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
28. Kojima H., Tanaka Y., Tanaka T., et al. Cell proliferation and apoptosis in human middle ear cholesteatoma. Arch Otolaryngol Head Neck Surg 124 (1998) 261-264
29. Holly A., Sittinger M., and Bujia J. Immunohistochemical demonstration of c-myc oncogene product in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 252 (1995) 366-369
30. Sudhoff H., Dazert S., Gonzales A.M., et al. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol 21 (2000) 793-798
31. Akimoto R., Pawankar R., Yagi T., et al. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec 62 (2000) 257-265
32. Banerjee A.R., Jones J.L., Birchall J.P., et al. Localization of matrix metalloproteinase 1 in cholesteatoma and deep meatal skin. Otol Neurotol 22 (2001) 579-581
33. Albino A.P., Reed J.A., Bogdany J.K., et al. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications. Am J Otol 19 (1998) 30-36
34. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
35. Hofseth L.J., Hussain S.P., and Harris C.C. p53: 25 years after its discovery. Trends Pharmacol Sci 25 (2004) 177-181
36. Watabe-Rudolph M., Rudolph K.L., Averbeck T., et al. Telomerase activity, telomere length, and apoptosis: a comparison between acquired cholesteatoma and squamous cell carcinoma. Otol Neurotol 23 (2002) 793-798
37. Shay J.W., and Wright W.E. Telomerase activity in human cancer. Curr Opin Oncol 8 (1996) 66-71
38. Ergun S., Carlsoo B., and Zheng X. Apoptosis in meatal skin, cholesteatoma and squamous cell carcinoma of the ear. Clin Otolaryngol Allied Sci 24 (1999) 280-285
39. Desloge R.B., Carew J.F., Finstad C.L., et al. DNA analysis of human cholesteatomas. Am J Otol 18 (1997) 155-159